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Abstract
Background: Alpha 2 Macroglobulin family members have been studied extensively with respect to their roles in physiology
and human disease including innate immunity and Alzheimer’s disease, but little is known about a possible role in liver
development loss-of-function in model systems.
Principal Findings: We report the isolation of the zebrafish a2 macroglobulin-like (A2ML) gene and its specific expression in
the liver during differentiation. Morpholino-based knock-down of A2ML did not block the initial formation of the liver
primordium, but inhibited liver growth and differentiation.
Significance: This report on A2ML function in zebrafish development provides the first evidence for a specific role of an
A2M family gene in liver formation during early embryogenesis in a vertebrate.
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Introduction
The a2 macroglobulin (A2M) family includes conserved blood
proteins with multiple functions, especially as protease inhibitors
[1,2,3,4]. While A2M is produced in the liver, multiple patterns of
tissue distribution and various functions, including a link to
Alzheimer’s disease, have been reported for different A2M family
members [5,6,7,8,9]. Complete A2M deficiency has not been
reported in humans, but mice with targeted mutations in the A2M
or the related murinoglobulin gene are viable and fertile, with
susceptibility to acute pancreatitis as the most apparent phenotype
[10,11]. In Xenopus laevis, the A2M-related genes endodermin (EDD)
andPanzaareexpressedinliverand inotherendodermalderivatives
[12,13], but developmental aspects of A2M family function in liver
development have not been reported in this or any other species.
Here we report the isolation of the zebrafish alpha-2 macroglobulin-like
(A2ML) gene, and show that it has a role in liver development in this
organism. Morpholino-based knock-down of A2ML does not block
the initial formation of the liver primordium, but growth and
development of the liver is disrupted largely by reduced cell
proliferation, without observable defects in pancreas and intestine
development. Thus we present evidence for the role of an A2M
family gene in liver formation during embryogenesis.
Results and Discussion
Liver specific expression of zebrafish A2ML
A partial sequence for the zebrafish a2-macroglobulin like gene
(A2ML) was listed under GenBank accession number BC125959
(IMAGE: 6996802), and is localized on chromosome 15 in the
Sanger Center Zebrafish Genome Data base (Scaffold Zv7_
scaffold1487 http://www.ensembl.org/Danio_rerio/). To extend
this sequence we performed the RACE procedure, obtaining full-
length A2ML cDNA (accession number EU689051). Zebrafish
A2ML contains three domains that are conserved in the vertebrate
A2M family (Fig. S1A–D). Zebrafish A2ML is more closely related
to human A2ML and to Xenopus Panza than to the prototype A2M
of human, mouse and Xenopus (Fig. 1K). Expression of A2ML
begins in the yolk syncytial layer (YSL) beneath the dorsal shield in
the zebrafish gastrula, as verified by two color in situ hybridization
with vent as a ventral marker [14,15] (Fig. 1A,B). Zygotic
expression of A2ML was confirmed by RT-PCR (Fig. 1L). A2ML
continues to be expressed in the YSL during mid gastrulation, as
confirmed by double-label staining with Casanova (cas) [16] and
transferrin a (tfa) [17,18] as endoderm and YSL markers,
respectively (Fig. 1C–E). Expression of A2ML in the liver starts
around 3.5 days post fertilization (dpf) (Fig. 1F), and continues at
later stages, in addition to expression in the epithelium
surrounding the yolk (Fig. 1G,H), while the pancreas rudiment is
negative at all stages tested (yellow arrow in Fig. 1H). By 7 dpf, the
liver continues strongly positive while the gut also shows
expression of A2ML (Fig. 1I,J). These data indicate that A2ML,
a member of the A2M family, is most strongly expressed in the
developing liver during early zebrafish development.
A2ML is not required for the initiation of liver formation
To study A2ML function in development, we used two anti-
sense morpholinos (MO) to inhibit its expression. One MO is
complementary to the 59-UTR (UTR MO) while the other targets
the translation start area (ATG MO). Fig. 2 compares embryos
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embryos exhibit largely normal development (90%, n= 87),
similar to embryos injected with cont MO (95%, n= 33)
(Fig. 2A,B). Because of the expression of A2ML in endoderm we
tested for early effects of the MO on liver and pancreas
development, using markers such as hhex [19], ceruloplasmin (cp)
[20], tfa, and foxa3 [21] (Fig. 2C–J). At 50 hpf, expression of these
markers in liver is partially reduced by A2ML MO, while the
pancreatic primordium is normal. Specificity of this MO was
tested using an A2ML-GFP fusion construct, whose expression is
effectively blocked by the morpholino (Fig. 2K,L). We also tested
hhex and cp expression at 24 hpf and detected no changes in liver
and pancreatic primodium development (data not shown). These
results indicate that the development of the liver and pancreas is
initiated normally in A2ML ATG MO-injected embryos, but that
liver formation begins to be affected after 2 days of development.
A2ML is essential for liver and gut, but not pancreas
formation
Knock-down of A2ML expression led to specific deficits in liver
formation that became more pronounced with time, without
causing widespread developmental defects. These results were
confirmed with the aid of the transgenic line Tg(XlEef1a1:GFP)
that allows visualization of intestinal organs [22]. Injection of
either UTR or ATG MO led to a strong reduction in the size,
albeit not complete disappearance, of the liver in 5 dpf embryos
(Fig. 3). Importantly, this defect could be rescued by co-injection of
the MOs with A2ML mRNA (Fig. 3).
This effect on liver formation was visualized with the aid of
molecular markers at five to sixdpf in Fig. 4. The expression domains
of liver specific markers such as intestinal fatty acid binding protein 10
(fabp10) [23] and tfa were greatly reduced after injection of A2ML
UTR or ATG MO (Fig. 4A–F and 4K–N; see 4Q, R for UTR MO
specificity).Asimilareffectwasalsoseenwiththelivermarkercp (data
not shown). The liver and pancreas form as protrusions from the gut
primordium during early development [24].
We also monitored possible effects of A2ML MO injection on
blood vessel formation in the liver by inspecting fliGFP transgenic
animals, and found no substantial defect in blood vessel formation
(Fig. S2A–B).
Because of the close relationship in the formation of these organs
we also tested whether A2ML MOs affect the formation of the gut
and pancreas with the aid of specific markers for these tissues. Using
the fabp2 as a marker [18], we find that the gut appears somewhat
reduced in size in 5 dpf embryos (Fig. 4H). A reduction in gut size
canalsobeseenbydirectinspectionofA2MLMO-injected embryos
(Fig. 3), but the effect of A2ML knock-down on gut formation
appearstobelessintensethantheeffectonthe liver.Thegoblet cells
in the developing intestine appeared to develop normally in A2ML
knockdown embryos (Fig. S2C–D). Expression of fabp10 and tfa in
the yolk region was completely lost after A2ML MO injection
(Fig. 4C–F and 4K–N), and these embryos failed to resorb their yolk
and to inflate a swim bladder, defects that were effectively rescued
by co-injection of mRNA (Fig. 3).
It is not known whether persistence of the yolk mass impedes gut
development in these embryos or reduced gut development is the
cause of poor yolk utilization after knock-down of A2ML
expression. Proper lipid utilization is required for yolk absorption
andnormaldevelopmentinzebrafish[25], and the liver has a major
role in lipid metabolism [26]. Thus, failure of proper liver growth in
the A2ML-deficient embryos may be an important cause of poor
yolk resorption and utilization. In contrast to the effects on liver and
gut formation, development of the pancreas appears unaffected by
Figure 1. Expression and phylogenic tree analysis of zebrafish A2ML. A–B. Lateral (A) and dorsal view (B) of restricted expression of A2ML
under the embryonic shield at 70% epiboly. (B) is double labeled with vent (red). Arrowheads in A and B point to the embryonic shield. C–E. 80%
epiboly stage. Lateral view of A2ML expression in the nucleus of YSL cells. (D) Two color in situ hybridization with cas (blue) and A2ML (red). (E)
Fluorescence in situ hybridization with tfa (green) and A2ML (red). F. Lateral view of A2ML expression in the liver at 3.5dpf. G–H. Restricted expression
of A2ML in liver and yolk (G) and transverse section (H) at 4.5dpf. Yellow arrowhead points to A2ML-negative pancreas rudiment. I–J. Lateral view of
A2ML expression at 7dpf. K. Phylogenic tree of A2M family. Ca, carp; H, human; M, mouse; X, Xenopus, Z, zebrafish. See Supplementary Material for
accession numbers. L. RT-PCR analysis of A2ML in development; Histone H4 and b-actin were used as controls. Arrows in F–I indicate developing liver,
and red arrowheads in F–I point to yolk. g, gut; y, yolk.
doi:10.1371/journal.pone.0003736.g001
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with insulin (ins) [27] at 5 dpf (Fig. 4I–J), and islet1 (isl1) [28] at 6 dpf
(Fig. 4O–P). Likewise, exocrine pancreas cells, observed using
immunoreactive carboxypeptidase A, develop normally in A2ML
MO injected embryos (Fig. S2E–F). Thus, A2ML is required for
liver growth and development and for gut development to a lesser
degree, but does not appear to have a role in pancreas formation.
A2ML is required for liver cell proliferation and tissue
differentiation
To probe further into the nature of the inhibition of liver
formation after A2ML knock-down we examined embryo sections
by histologic techniques. Methylene blue-stained sections of
embryos at 5.5 dpf further illustrate the morphological differences
between control and A2ML knock-down embryos (Fig. 5C,D).
The pancreas was not affected by A2ML ATG MO injection,
while the yolk mass is prominent in the knock-down embryo
compared to the control MO-injected embryo (Fig. 5C,D). While
pancreas and gut cross-sections are similar to controls at this stage,
the liver is greatly reduced and in fact is not present in the section
shown in Fig. 5D. An enlarged section of the liver shows reduced
density of nuclei and increased vacuolization in the A2ML-
deficient liver (Fig. 5E,F). A deficit in lipid metabolism is also
suggested by the greatly increased staining with Oil Red O in the
remaining liver tissue of these embryos (Fig. 5G,H). Lack of liver
differentiation is apparent in the essentially total loss of P-
glycoprotein staining in the livers of embryos injected with the
A2ML ATG MO or UTR MO (Fig. 5J,K); this effect was rescued
by injection of A2ML mRNA (Fig. 5L).
The great reduction in liver size together with the cellular
changes seen in Figures 5E and 5F could be explained by an
increase in cell death, a decrease in proliferation, or both.
Apoptosis was not increased in A2ML MO-injected embryos
compared to controls (Fig. 6A–B9). In contrast, proliferation of
hepatocytes as tested by anti-phospho histone 3 (PH3) antibody
staining showed a clear reduction in A2ML knock-down embryos
(Fig. 6C,D and G). In contrast, proliferation of intestinal cells was
not obviously compromised in these embryos at the same stage
(Fig. 6E–H). It is possible that proliferation in the gut decreases
during later development as we observe a reduction in the size of
the gut in A2ML knock-down embryos starting at a later stage
than for the liver. Thus, inhibition of A2ML expression leads to
reduced proliferation in the liver primordium and inhibits
differentiation of those cells that remain in the diminished organ.
Concluding remarks
A2M family proteins are major products of the liver. We have
isolated the gene encoding a member of this family, A2ML, from
zebrafish and shown that it is expressed in endodermal precursors
and subsequently in the liver. Inhibition of A2ML expression with
the aid of antisense MOs led to strong reduction in the size of the
developing liver without any effect on the formation of the
pancreas. This observation is of interest in the sense that a protein
normally thought of as a product of the liver proves to be required
for liver formation, specifically for cell proliferation in the liver
rudiment. These results suggest a relationship between physiology
and development in liver organogenesis.
The relationship of zebrafish A2ML to members of the protein
family in other vertebrates is difficult to evaluate, mostly because of
an incomplete understanding of orthology relationships. Functions
and possible disease relationships of the prototypical A2M has
been studied extensively in humans (see Introduction), but
knockout of the apparent ortholog in the mouse is viable and
fertile [10,11]. The protein we describe in zebrafish appears more
closely related to human A2ML (Fig. 1K), a protein discovered
more recently and described as a factor with a role in epidermis
[29]. Based on existing information, human and zebrafish A2ML
have no functional communality, but neither protein has been
studied exhaustively to date. The group of A2ML proteins also
includes Xenopus Panza (Fig. 1K) about whose function little is
known, but no similar mouse protein has been reported. A search
of sequence data bases has not revealed a zebrafish gene more
closely related to the prototypical A2M, but the zebrafish genome
is not yet complete and the issue thus remains unresolved. Thus,
the evolutionary and functional relationships in the A2M protein
family remain to be elucidated by future work.
Figure 2. A2ML knock-down phenotype. A2ML ATG MO-injected
embryos were at 50 hpf (A–J); embryos in the MO specificity test were
at the 3-somite stage (K–L). A–B. Lateral view of live images of control
and A2ML ATG MO-injected embryos. C–J. Dorsal views of whole
mount in situ hybridization with hhex (C–D), cp (E–F), tfa (G–H), and
foxa3 (I–J) of cont MO (C, E, G, I) and A2ML ATG MO (D, F, H, J) injected
embryos. A yellow arrow in (I) points to the developing hepatopancre-
atic duct. K–L. An A2ML-GFP fusion construct was expressed in 95%
(n=40) of embryos after coinjection with control MO, while coinjection
of A2ML ATG MO blocked expression of the fusion construct in 95% (n=
55) of embryos. h, heart; L, liver; p, pancreatic primodium.
doi:10.1371/journal.pone.0003736.g002
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Zebrafish Maintenance
The ef1a transgenic line, Tg(XlEef1a1:GFP)s854/+, was obtained
from Zebrafish International Resource Center (ZIRC. http://
zebrafish.org/zirc/home/guide.php) and fli-gfp transgenic zebra-
fish were obtained from Dr. Brant Weinstein (NICHD/NIH).
Isolation of Full-length A2ML
The full-length A2ML sequence was completed by 59-a n d3 9-
RACE (BD Biosciences Clontech), using 59-GCAGCGGT-
GAAACTCTTGCTCAGCATTC-39 (59-RACE) and 59-CTT-
CACTGTCAAATACGATG GGCCAGAG-39 (39-RACE). Sub-
cloning into pCS2
+ used primers 59-GAATTCGTCAT-
CATGGCTCTGAA TGTTAGC and 39-CTCGAGTTAATT
GATGTTCTTCAGTGCTTC, introducing 59 EcoRI and 39 XhoI
sites. Amino acid comparisons and phylogenic tree analysis were
carried out with DNASIS MAX version 2.0 (MiraiBio, Hitachi
software).
In Situ Hybridization
Whole-mount in situ hybridization with alkaline phosphatase-
based single or double color staining has been described [30].
Double fluorescent in situ hybridization (FISH) was performed as
described [31]. The green color detection used the tyramide signal
amplification Kit with horseradish peroxidase, and the red color
was Cy3 (PerkinElmer).
Microinjection of A2ML RNA and Morpholinos
A2ML ATG MO (59-ACAACAGCTAACATTCAGAGC-
CATG-39) and UTR MO (59-CAGAGCCATGATGAC-
GAGTGTCCAG -39) were synthesized by Gene Tools. The
Figure 3. A2ML MOs affect liver formation. Embryos from the ef1a-GFP transgenic line are shown at 5dpf. A–A0. cont MO-injected embryos (95%
normal, n=30). B–B0. A2ML ATG MO-injected embryos showed reduced liver in 90% (n=45) of cases. C–C0 Rescue of A2ML ATG MO phenotype by
co-injection with A2ML mRNA (80% rescued, n=45). D–D0. Cont MO-injected embryos (99% normal, n=35). E–E0. A2ML UTR MO injected embryos
(98% defect, n=55). F–F0. Rescue of A2ML UTR MO phenotype by co-injection with A2ML mRNA (90% rescued, n=47). See Experimental Procedures
for injection levels. Red outlines in B9 and E9 represent the small livers remaining in these embryos. Asterisks in B9 and E9 identify yolk. g, gut; h, heart;
L, liver; sb, swim bladder.
doi:10.1371/journal.pone.0003736.g003
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5dpf A–J or 6dpf K–P. A, B, K, L. Lateral views of fabp10-stained embryos. C–F, M–N. Lateral (C, D, M, N) and dorsal views (E–F) of tfa expression. G–
H. Lateral views of fabp2 expression. I–J. Lateral view of insulin expression, and O–P. islet1 expression in the pancreas. Q–R. Specificity test using the
UTR MO at the 3-somite stage; see Fig. 2K–L.
doi:10.1371/journal.pone.0003736.g004
Figure 5. A2ML knock-down phenotypes in the liver. Embryos
injected with cont MO (A, C, E, G, I), A2ML ATG MO (B, D, F, H, J),
A2ML UTR MO (K), and embryo rescued by co-injection of ATG MO and
mRNA (L) were analyzed at 5.5 dpf. (C–F) plastic sections, (G–L)
cryosections. A–B Lateral live images in the area of the liver (indicated
by red dotted line); the short vertical line indicates the plane of section
for C and D, the long line for E–L. C–D Methylene blue stain. Red
arrowhead points to pancreas, red arrow to liver (in C). E–F
Hematoxylin and Eosin (H&E) stained liver section. Asterisks are
sinusoids. G–H Lipid staining of liver using Oil-Red O for cont MO (G)
and A2ML ATG MO-injected embryos (H). I–L Confocal images for P-
glycoprotein IHC; either MO eliminates P-glycoprotein staining (J and
K), while mRNA coinjection rescues staining (L). Scale bars represent
10 mm in E–F and 50 mm in G–L. g, gut; h, hepatocytes; L, liver; n,
notochord; pe, pectoral fin; y, yolk.
doi:10.1371/journal.pone.0003736.g005
Figure 6. TUNEL and PH3 staining in A2ML ATG MO-injected
embryos. All embryos were at 5 dpf. A–D are transverse section, and
E–F sagital section. A–B9 TUNEL staining of cont MO-injected embryo
(A), and knock-down embryo (B). Areas in open square in A and B are
magnified in the A9 and B9. C–D Confocal images of sections stained
with anti-PH3
ser10 antibody. E–F PH3 staining in the intestine in cont
MO (E) and in A2ML ATG MO-injected embryos (F). G Quantification of
PH3-positive liver cells. Scale bars in (A and B) 20 mm, and in (C–F)
50 mm. es, esophagus; L, liver; y, yolk.
doi:10.1371/journal.pone.0003736.g006
A2ML in Liver Development
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MO, 2 ng; all were injected into one-cell stage embryos. For
rescue, 30 pg of A2ML-eGFP RNA was used; the same level was
used for specificity tests.
Histology
Sections were cut after embedding in JB-4 plastic (Polysciences)
at 7 mm, or in OCT medium for cryosectioning (Tissue-Tek) at
10 mm for immunohistochemistry (IHC). Embryos were fixed in
4% paraformaldehyde for 2 hours at 4u. For IHC, sections were
soaked for 2 min in acetone, followed by 30 min in 10 mM
sodium citrate (pH 6.0) in PBS (0.1% Triton X-100). Blocking was
done with 2% goat serum in PBS-Tween 20 for 30 min at room
temperature. Methylene blue staining has been described [30].
IHC was performed as follows: anti-PH3
ser10 at 1:500 (Upstate),
anti P-glycoprotein at 1:300 (Abcam), anti-bovine carboxypepti-
dase A at 1:500 (Rockland Inc) [32]. Fluorescein conjugated wheat
germ agglutinin (Vector lab) [33] was diluted in 1xPBS at 1:100
and incubated overnight at 4u. Alexa Fluor 488-conjugated anti-
mouse IgG and Alexa Fluor 568-conjugated goat anti-rabbit IgG
were used as secondary antibodies (Invitrogen). TUNEL reagents
were from Invitrogen, and sections were counter stained with
Gill’s hematoxylin. Lipid staining of cryosections used 0.5% Oil-
red O (Sigma) in propylene glycol. Confocal imaging was done
with a Zeiss LSM 510 laser-scanning confocal microscope.
Supporting Information
Figure S1 Amino acid comparison of A2ML family. Amino acid
comparison of a2ML family. A. Schematic representation of
amino acid sequence comparison between species. The percentage
identity to zebrafish a2 macroglobulin-like is given for N-terminal
(N), middle (M), and C-terminal (C) regions, and for the entire
proteins to the right. B. The bait regions (bold underline) are
compared. C. The highly conserved thio ester region. A glycine
and glutamine (asterisks) represent essential amino acids that form
thio ester bonds. D. C-terminal highly conserved target binding
domain (CHB) (bold underline). The accession number for A2M
family are carp A2M-1 (AB026128); Xenopus laevis Panza
(DQ080115); Xenopus laevis EDD (L63543); Human A2M
(BC040071); Human A2ML1 (NM144670); Mouse A2M
(BC072642).
Found at: doi:10.1371/journal.pone.0003736.s001 (5.97 MB TIF)
Figure S2 Development of blood vessels, goblet cells, and
exocrine pancreas. Embryo stages are 5 dpf for A–D, and 4dpf for
E–F. A–B. Blood vessel formation of control MO (A) and A2ML
MO (B) injected embryos as visualized in fli1-gfp Tg embryos. C–
D. Confocal images of goblet cells in intestine were obtained using
fluorescein-conjugated wheat germ agglutinin in control MO (C)
and A2ML MO (D) injected embryos. E–F. Confocal images of
immunoreactive carboxypeptidase A showing exocrine cells in the
pancreas in cont MO (E) and A2ML MO (F) injected embryos. L,
liver.
Found at: doi:10.1371/journal.pone.0003736.s002 (8.65 MB TIF)
Acknowledgments
We thank John M. Gonzales for fish care.
Author Contributions
Conceived and designed the experiments: SKH IBD. Performed the
experiments: SKH. Analyzed the data: SKH IBD. Wrote the paper: SKH
IBD.
References
1. Van Leuven F, Marynen P, Cassiman JJ, Van den Berghe H (1988) Proteolysis
of human alpha 2-macroglobulin without hydrolysis of the internal thiolesters or
expression of the receptor recognition site. J. Biol. Chem 263: 468–471.
2. Huang W, Dolmer K, Liao X, Gettins PGW (2000) NMR Solution Structure of
the Receptor Binding Domain of Human a2-Macroglobulin. J. Biol. Chem 275:
1089–1094.
3. Sottrup-Jensen L (1989) Alpha-macroglobulins: structure, shape, and mecha-
nism of proteinase complex formation. J. Biol. Chem 264: 11539–11542.
4. Armstrong PB (2006) Proteases and protease inhibitors: a balance of activities in
host-pathogen interaction. Immunobiology 211: 263–281.
5. Du Y, Ni B, Glinn M, Dodel RC, Bales KR, et al. (1997) alpha2-Macroglobulin
as a beta-amyloid peptide-binding plasma protein. J Neurochem 69: 299–305.
6. Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, et al. (1998) Alpha-2
macroglobulin is genetically associated with Alzheimer disease. Nat Genet 19:
357–360.
7. Narita M, Holtzman DM, Schwartz AL, Bu G (1997) Alpha2-macroglobulin
complexes with and mediates the endocytosis of beta-amyloid peptide via cell
surface low-density lipoprotein receptor-related protein. J Neurochem 69:
1904–1911.
8. Tayade C, Esadeg S, Fang Y, Croy BA (2005) Functions of alpha 2
macroglobulins in pregnancy. Mol Cell Endocrinol 245: 60–66.
9. Galliano MF, Toulza E, Gallinaro H, Jonca N, Ishida-Yamamoto A, et al. (2006)
A novel protease inhibitor of the alpha2-macroglobulin family expressed in the
human epidermis. J. Biol. Chem 281: 5780–5789.
10. Umans L, Serneels L, Overbergh L, Lorent K, Van Leuven F, et al. (1995)
Targeted Inactivation of the Mouse a2-Macroglobulin Gene. J. Biol. Chem 270:
19778–19785.
11. Umans L, Serneels L, Overbergh L, Stas L, Van Leuven F (1999) alpha2-
macroglobulin- and murinoglobulin-1- deficient mice. A mouse model for acute
pancreatitis. Am J Pathol 155: 983–993.
12. Sasai Y, Lu B, Piccolo S, De Robertis EM (1996) Endoderm induction by the
organizer-secreted factors chordin and noggin in Xenopus animal caps. EMBO J
15: 4547–4555.
13. Pineda-Salgado L, Craig EJ, Blank RB, Kessler DS (2005) Expression of Panza,
an alpha2-macroglobulin, in a restricted dorsal domain of the primitive gut in
Xenopus laevis. Gene Expr Patterns 6: 3–10.
14. Melby AE, Beach C, Mullins M, Kimelman D (2000) Patterning the early
zebrafish by the opposing actions of bozozok and vox/vent. Dev Biol 224:
275–285.
15. Kawahara A, Wilm T, Solnica-Krezel L, Dawid IB (2000) Functional interaction
of vega2 and goosecoid homeobox genes in zebrafish. Genesis 28: 58–67.
16. Kikuchi Y, Agathon A, Alexander J, Thisse C, Waldron S, et al. (2001) casanova
encodes a novel Sox-related protein necessary and sufficient for early endoderm
formation in zebrafish. Genes Dev 15: 1493–1505.
17. Kudoh T, Tsang M, Hukriede NA, Chen X, Dedekian M, et al. (2001) A gene
expression screen in zebrafish embryogenesis. Genome Res 11: 1979–1987.
18. Mudumana SP, Wan H, Singh M, Korzh V, Gong Z (2004) Expression analyses
of zebrafish transferrin, ifabp, and elastaseB mRNAs as differentiation markers
for the three major endodermal organs: liver, intestine, and exocrine pancreas.
Dev Dyn 230: 165–173.
19. Ho CY, Houart C, Wilson SW, Stainier DY (1999) A role for the
extraembryonic yolk syncytial layer in patterning the zebrafish embryo suggested
by properties of the hex gene. Curr Biol 9: 1131–1134.
20. Korzh S, Emelyanov A, Korzh V (2001) Developmental analysis of
ceruloplasmin gene and liver formation in zebrafish. Mech Dev 103: 137–139.
21. Odenthal J, Nu ¨sslein-Volhard C (1998) fork head domain genes in zebrafish.
Dev Genes Evol 208: 245–258.
22. Field HA, Ober EA, Roeser T, Stainier DYR (2003) Formation of the digestive
system in zebrafish. I. liver morphogenesis. Dev Biol 253: 279–290.
23. Her GM, Chiang CC, Chen WY, Wu JL (2003) In vivo studies of liver-type fatty
acid binding protein (L-FABP) gene expression in liver of transgenic zebrafish
(Danio rerio). FEBS Lett 538: 125–33.
24. Ober EA, Field HA, Stainier DY (2003) From endoderm formation to liver and
pancreas development in zebrafish. Mech Dev 120: 5–18.
25. Schlegel A, Stainier DY (2006) Microsomal triglyceride transfer protein is
required for yolk lipid utilization and absorption of dietary lipids in zebrafish
larvae. Biochemistry 45: 15179–15187.
26. Nguyen P, Leray V, Diez M, Serisier S, Le Bloc’h J, et al. (2008) Liver lipid
metabolism. J Anim Physiol Anim Nutr (Berl) 92: 272–283.
27. Huang H, Vogel SS, Liu N, Melton DA, Lin S (2001) Analysis of pancreatic
development in living transgenic zebrafish embryos. Mol Cell Endocrinol 177:
117–124.
28. Manfroid I, Delporte F, Baudhuin A, Motte P, Neumann CJ, et al. (2007)
Reciprocal endoderm-mesoderm interactions mediated by fgf24 and fgf10
govern pancreas development. Development 134: 4011–4021.
29. Galliano MF, Toulza E, Jonca N, Gonias SL, Serre G, et al. (2008) Binding of
alpha2ML1 to the low density lipoprotein receptor-related protein 1 (LRP1)
reveals a new role for LRP1 in the human epidermis. PLoS ONE 23: e2729.
A2ML in Liver Development
PLoS ONE | www.plosone.org 6 November 2008 | Volume 3 | Issue 11 | e373630. Hong SK, Haldin CE, Lawson ND, Weinstein BM, Dawid IB, et al. (2005) The
zebrafish kohtalo/trap230 gene is required for the development of the brain,
neural crest, and pronephric kidney. Proc Natl Acad Sci USA 102:
18473–18478.
31. Kosman D, Mizutani CM, Lemons D, Cox WG, McGinnis W, et al. (2004)
Multiplex detection of RNA expression in Drosophila embryos. Science 305:
846.
32. Pack M, Solnica-Krezel L, Malicki J, Neuhauss SC, Schier AF, et al. (1996)
Mutations affecting development of zebrafish digestive organs. Development
123: 321–328.
33. Wallace KN, Akhter S, Smith EM, Lorent K, Pack M (2005) Intestinal growth
and differentiation in zebrafish. Mech Dev 122: 157–173.
A2ML in Liver Development
PLoS ONE | www.plosone.org 7 November 2008 | Volume 3 | Issue 11 | e3736